Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

RCMP warns of new drug with similar effects to fentanyl in Nova Scotia

Global News

Nova Scotia RCMP is warning of a new drug found during a seizure on Nov. 26 last year, described as white, triangular-shaped tablets with a line down the middle.

Story continues below advertisement

The letter ‘’M’’ is on one side and the number “8” is on the other side, police said.

According to authorities, the drugs were seized from a motor vehicle entering Nova Scotia from New Brunswick. Among the drugs seized was a small quantity of white pills and purple powder in a plastic bag.

“Both the powder and the pills were sent to Health Canada for analysis,” police said in a press release.

The daily email you need for 's top news stories.

The results have come back advising that Isotonitazene, a controlled substance, was found in both the pills and the purple powder.

Police said Health Canada also advised that Isotonitazene is an opioid with similar effects to fentanyl. Like fentanyl, it can slowly be absorbed through the skin, so it is potentially dangerous to handle without taking appropriate health and safety precautions.

Story continues below advertisement

“Given the current limited state of knowledge regarding Isotonitazene, caution is recommended,” the RCMP said.

“RCMP always warn against illicit drug use, however, with the presence of this new substance in drugs seized in a Nova Scotia, the danger of illicit drug use has increased.”

The RCMP advised that free Naloxone kits are available throughout the province for anyone at risk of overdose, as well as friends and family of someone at risk of overdose.

Story continues below advertisement

These kits can temporarily reverse the effects of an opioid overdose.

Find a pharmacy that distributes Naloxone near you at nsnaloxone.com.

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article